Implementation of new technologies in the nutritional assessment of chronic hepatic patients
DOI:
https://doi.org/10.52556/2587-3873.2023.4(97).23Keywords:
chronic liver pathology, bioelectrical impedance analysis, nutritional stare, total cholesterol, HDL, LDL, triglyceridesAbstract
In liver pathology, lipid metabolism is significantly affected. Along with the use of routine laboratory methods for diagnosing nutritional stare and metabolic disorders including dislipidemia, there is a need for simple, accurate and non-invasive methods for assessing body composition, such as bioelectrical impedance analysis (BIA). Materials and methods. There were examined 282 patients with chronic liver pathology, 75 patients with chronic viral hepatitis (HVC group), 96 patients with hepatic steatosis (SH group), 111 patients with liver cirrhosis (CH group). BIA indicators: BMI, percentage of body fat (PBF), indicator of the proportion of visceral fat (PVF) and total cholesterol, HDL, LDL and triglycerides (TG) in serum were determined. Results. BMI in the SH-G was found 30.29±0.50, in the HVC-G - 28.13±0.65, in the CH-G - 22.69±0.16 kg/m². PBF: 36.02±1.06 (SH-G), 34.16±1.33 (HVC-G), 22.90±0.85% (CH-G). PVF in the SH-G was 12.03±0.50, in the HVC-G it was 10.60±0.58, in the CH-G it was 7.06±0.28%. LDL: 3.73±0.13 (SH-G), 3.02±0.14 (HVC-G), 2.35±0.15 mmol/l (CH-G). TG in the SH-G - 1.87±0.11, in the HVC-G - 1.48±0.22, in the CH-G - 0.80±0.04 mmol/l. Conclusion. The highest rates of both biochemical and BIA are observed in patients with SH, and the lowest in the CH. To study lipid metabolism and evaluate the nutrition stare of patients with chronic liver disease, noninvasive methods such as BIA can be recommended.
References
1. Kotlyarov S., Bulgakov A. Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease. In: cells. 2021 Nov 1, vol. 10(11), p. 2978. https://doi.org/10.3390/cells10112978
2. Kao Y-C. et al. Lipids and Alzheimer's Disease. In: Int J Mol Sci. 2020 Feb 22, vol. 21(4), pp. 1505. https://doi.org/10.3390/ijms21041505
3. Paul B. et al. Lipid alterations in chronic liver disease and liver cancer. In: JHEp Rep. 2022, vol. 4(6), p.100479. https://doi.org/10.1016/j.jhepr.2022.100479
4. Bian X. et al. Lipid metabolism and cancer. In: J Exp Med. 2021 Jan 4, vol. 218(1), p. e20201606. https://doi.org/10.1084/jem.20201606
5. Ritchie J.D. et al. Tanita foot-to-foot bioelectrical im-pedance analysis system validated in older adults. In: J am Diet assoc. 2005, vol. 105(10), pp. 1617-1619. https://doi.org/10.1016/j.jada.2005.07.011
6. Тухватулина Г. В. и др. Лабораторная диагностика нарушений липидного обмена. В Вестник современной клинической медицины, 2013, том 6, приложение 1, cc. 46-49.
7. Kim D.Y. et al. Boesenbergia pandurata attenuates diet-induced obesity by activating AMP-activated protein kinase and regulating lipid metabolism. In: Int J Mol Sci. 2012, vol. 13(1), pp. 994-1005. https://doi.org/10.3390/ijms13010994
8. Schoeler M., Caesar R. Dietary lipids, gut microbiota and lipid metabolism. In: Rev Endocr Metab Disord. 2019, vol. 20(4), pp. 461-472. https://doi.org/10.1007/s11154-019-09512-0
9. Hannon B.A. et al. Nutrigenetic Contributions to Dyslipidemia: A Focus on Physiologically Relevant Pathways of Lipid and Lipoprotein Metabolism. In: nutrients. 2018, vol. 10, pp. 1404. https://doi.org/10.3390/nu10101404
10. Kubicek-Sutherland J.Z. et al. Detection of Lipid and Amphiphilic Biomarkers for Disease Diagnostics. In: Biosensors (Basel). 2017, vol. 7(3), p. 25. https://doi.org/10.3390/bios7030025
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
